Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke.
Lakhan SE, Kirchgessner A, Tepper D, Leonard A. · 2013
Read Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke. by Lakhan SE, Kirchgessner A, Tepper D, Leonard A. (2013) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3615191.txt.
Description
Shaheen Lakhan and colleagues reviewed enzymes that tear down the blood-brain barrier in stroke in Frontiers in Neurology in 2013. The barrier seals brain blood vessels, and its failure after a blocked artery worsens injury. The only approved stroke drug, tPA, dissolves clots but turns dangerous with time, largely through bleeding into the brain. Matrix metalloproteinases, enzymes that cut the scaffolding proteins of tissue, stand accused of opening the barrier and enabling that bleeding.
One family member, MMP-9, takes the lead role in the evidence for tPA-linked bleeding. Oxygen radicals worsen the picture by destroying caveolin-1, a protein that normally keeps the barrier tight, which in turn lets tPA activate more of the cutting enzymes. The review walks the chain from vessel blockage to barrier failure and asks whether blocking these enzymes alongside tPA could stretch the treatment window safely. That combination idea frames the research agenda.
Catalog record
| CREATOR | Lakhan SE, Kirchgessner A, Tepper D, Leonard A. |
|---|---|
| YEAR | 2013 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 96 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |